ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Study: Cylinder’s Digital Digestive Care Program Improves Symptoms and Drives Health Equity

CHICAGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cylinder, the employee benefit provider for gastrointestinal (GI) care, today announced that a clinical study of its app-based digestive health management platform found it to be effective in reducing health disparities and improving health outcomes across diverse racial and socioeconomic groups.

The peer-reviewed findings were published this month in BMJ Open Gastroenterology in a study titled “Digital disease management programme reduces chronic gastrointestinal symptoms among racially and socially vulnerable populations.”

The study evaluated the impact of Cylinder’s app-based digestive health management platform - which includes symptom tracking, personalized medical nutrition therapy, GI-specific health coaching, and targeted education - across a population that is diverse in race, gender, and socioeconomic status.

Key findings from the study include:

  • 85% of users reported significant improvements in GI symptoms.
  • 83% of users reported feeling more in control of their health, with African American users (92%) and women (86%) reporting the highest improvement.
  • 83% of users reported better symptom management, with African American users (94%) and women (88%) reporting the greatest improvement.
  • 76% of users reported feeling happier, with African American users (89%) reporting the highest improvement.

“Cylinder’s digestive health management platform can help address health inequities by offering greater access to information and care for chronic digestive issues,” said Bill Snyder, Founder and CEO of Cylinder. “For employers and healthcare providers looking to tackle the social and economic burdens of GI issues, this research offers evidence of a promising approach to improving the well-being and productivity of workers.”

According to the Cylinder 2024 State of Gut Health in the Workplace survey, 71% of Americans experience GI symptoms such as gas, bloating, abdominal pain, and constipation. The study emphasizes how the app-based tool can address these digestive health issues, particularly with underserved populations.

“In the United States, socially vulnerable groups have historically had limited access to information and care for their digestive health issues, resulting in poorer health outcomes such as colorectal cancer and GERD,” said Dr. Hau Liu, Chief Medical Officer for Cylinder. “Our study shows evidence that Cylinder’s digital health management tool can help support employers’ efforts to mitigate disparities in healthcare delivery, reduce healthcare costs, and improve the quality of life for workers of diverse backgrounds.”

About Cylinder
Founded in 2021 and offered as an employer benefit, Cylinder (formerly Vivante Health) delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform. Cylinder’s tech-forward, human-first program connects members to the right level of support at the right time through an easy interface – decreasing costs, reducing absenteeism, and improving their quality of life, at scale. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive healthcare they need to improve their overall health. Learn more at cylinderhealth.com.

Media Contact:
Sergut Dejene
sergut@propllr.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.96
+0.00 (0.00%)
AAPL  270.01
+0.00 (0.00%)
AMD  246.27
+0.00 (0.00%)
BAC  54.03
+0.00 (0.00%)
GOOG  344.90
+0.00 (0.00%)
META  706.41
+0.00 (0.00%)
MSFT  423.37
+0.00 (0.00%)
NVDA  185.61
+0.00 (0.00%)
ORCL  160.06
+0.00 (0.00%)
TSLA  421.81
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.